- Report
- May 2026
- 140 Pages
Global
From €2683EUR$2,999USD£2,295GBP
€3578EUR$3,999USD£3,060GBP
- Report
- August 2026
- 192 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 191 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- August 2026
- 107 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- October 2025
- 160 Pages
Global
From €2827EUR$3,160USD£2,418GBP
€3534EUR$3,950USD£3,022GBP
- Report
- January 2026
- 199 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 280 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- June 2026
- 130 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- September 2025
- 150 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- June 2026
- 53 Pages
Global
From €6711EUR$7,500USD£5,739GBP
- Report
- April 2026
- 293 Pages
North America
From €5364EUR$5,995USD£4,587GBP
- Report
- April 2026
- 335 Pages
Europe
From €5364EUR$5,995USD£4,587GBP
- Report
- April 2026
- 329 Pages
Asia Pacific
From €5364EUR$5,995USD£4,587GBP
- Report
- March 2026
- 90 Pages
North America
From €3087EUR$3,450USD£2,640GBP
- Report
- October 2025
- 99 Pages
Asia Pacific
From €4026EUR$4,500USD£3,443GBP
- Report
- July 2025
- 150 Pages
United States
From €5324EUR$5,950USD£4,553GBP
- Report
- July 2025
- 150 Pages
Global
From €5324EUR$5,950USD£4,553GBP
- Report
- November 2023
- 98 Pages
Global
From €3579EUR$4,000USD£3,061GBP

Renal Denervation is a minimally invasive procedure used to treat hypertension, or high blood pressure, by targeting the nerves that control the kidneys. It is a type of cardiovascular device that works by blocking the signals that cause the kidneys to produce hormones that increase blood pressure. The procedure is performed using a catheter that is inserted into the femoral artery and guided to the renal artery. Once in place, the catheter delivers radiofrequency energy to the renal nerves, which disrupts the signals that cause the kidneys to produce hormones that increase blood pressure.
Renal Denervation is a relatively new procedure, but it has been gaining traction in recent years as an effective treatment for hypertension. It is a safe and minimally invasive procedure that can be performed in an outpatient setting, and it has been shown to reduce blood pressure in patients with resistant hypertension.
Some companies in the Renal Denervation market include Medtronic, Abbott, Boston Scientific, and ReCor Medical. Show Less Read more